Institute of Sport, Warsaw, Poland.
University of Technology, Opole, Poland.
Biol Sport. 2013 Sep;30(3):155-61. doi: 10.5604/20831862.1059606. Epub 2013 Jul 22.
Genes control biological processes such as muscle production of energy, mitochondria biogenesis, bone formation, erythropoiesis, angiogenesis, vasodilation, neurogenesis, etc. DNA profiling for athletes reveals genetic variations that may be associated with endurance ability, muscle performance and power exercise, tendon susceptibility to injuries and psychological aptitude. Already, over 200 genes relating to physical performance have been identified by several research groups. Athletes' genotyping is developing as a tool for the formulation of personalized training and nutritional programmes to optimize sport training as well as for the prediction of exercise-related injuries. On the other hand, development of molecular technology and gene therapy creates a risk of non-therapeutic use of cells, genes and genetic elements to improve athletic performance. Therefore, the World Anti-Doping Agency decided to include prohibition of gene doping within their World Anti-Doping Code in 2003. In this review article, we will provide a current overview of genes for use in athletes' genotyping and gene doping possibilities, including their development and detection techniques.
基因控制着生物过程,如肌肉产生能量、线粒体生物发生、骨形成、红细胞生成、血管生成、血管舒张、神经发生等。对运动员进行 DNA 分析揭示了可能与耐力能力、肌肉表现和力量运动、肌腱易受伤和心理适应性相关的遗传变异。已经有几个研究小组确定了 200 多个与身体表现相关的基因。运动员的基因分型正在发展成为一种制定个性化训练和营养计划的工具,以优化运动训练,预测与运动相关的损伤。另一方面,分子技术和基因治疗的发展带来了非治疗性使用细胞、基因和遗传元件以提高运动表现的风险。因此,世界反兴奋剂机构于 2003 年决定将基因兴奋剂纳入其世界反兴奋剂法典的禁止范围。在这篇综述文章中,我们将提供目前用于运动员基因分型和基因兴奋剂可能性的基因概述,包括其开发和检测技术。